1. Home
  2. News
  3. Brii Biosciences Limited
  4. 2026 Interim Report
More Brii Biosciences Limited news
Brii Biosciences LimitedHKEX: 2137

2026 Interim Report

Sep 17, 2026 at 4:30 AM EDT · Issued by Brii Biosciences Limited via HKEXnews

Filed with HKEX · Stock code 2137 · Sep 17, 2026 at 4:30 AM EDT · 73 pages · English

On 6ix: 6ix.com/news/2026-interim-report-181

Brii Biosciences Limited on 6ix

Earlier from Brii Biosciences

  • Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial ResultsAug 20
  • Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis BJul 3
  • Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBVMay 27
  • Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026Apr 26
  • Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial ResultsMar 19

Later from Brii Biosciences

  • Notification Letter and Change Request Form for Registered ShareholdersSep 17
  • Notification Letter and Request Form for Non-registered ShareholdersSep 17
  • Monthly return of equity issuer on movements in securities for the month ended 30 September 2026Oct 7
  • Grant of share options and restricted share unitsOct 8
  • Next Day Disclosure ReturnOct 9
All Brii Biosciences news releases↗

Follow Brii Biosciences into a list and get an email when it puts out news.

Follow Brii Biosciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer